Antagonism of the effects of the hallucinogen dom and the purported 5-HT agonist quipazine by 5-HT2 antagonists

A SIMPLIFIED METHOD OF EVALUATING DOSE-EFFECT EXPERIMENTS

Litchfield, J. T., & Wilcoxon, F. (1949) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)03549-9 · Cited by 7,798

Multiple Serotonin Receptors: Differential Binding of [3H]5-Hydroxytryptamine, [3H]Lysergic Acid Diethylamide and [3H]Spiroperidol

Peroutka, S. J., & Snyder, S. H. (1979) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13812-1 · Cited by 1,363

[3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role.

Leysen, J. E., Niemegeers, C. J. E., Nueten, J. M. V., & Laduron, P. M. (1982) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14623-3 · Cited by 1,071

Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptors

Leysen, J. E., Awouters, F. H. L., Kennis, L. E. J., Laduron, P. M., Vandenberk, J., & Janssen, P. A. J. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90747-5 · Cited by 843

Two Distinct Central Serotonin Receptors with Different Physiological Functions

Peroutka, S. J., Lebovitz, R. M., & Snyder, S. H. (1981) · Science · doi:10.1126/science.7221567 · Cited by 639

A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist.

Colpaert, F. C., Niemegeers, C. J. E., & Janssen, P. A. J. (1982) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33038-7 · Cited by 168

Quipazine: Its effects on rat brain 5-hydroxytryptamine metabolism, monoamine oxidase activity and behaviour

Green, A. R., Youdim, M. B. H., & Smith, A. D. (1976) · Neuropharmacology · doi:10.1016/0028-3908(76)90026-5 · Cited by 120

Drug‐induced discrimination: A description of the paradigm and a review of its specific application to the study of hallucinogenic agents

Glennon, R. A., Rosecrans, J. A., & Young, R. (1983) · Medicinal Research Reviews · doi:10.1002/med.2610030305 · Cited by 89

A BEHAVIOURAL AND BIOCHEMICAL STUDY IN RATS OF 5‐HYDROXYTRYPTAMINE RECEPTOR AGONISTS AND ANTAGONISTS, WITH OBSERVATIONS ON STRUCTURE‐ACTIVITY REQUIREMENTS FOR THE AGONISTS

GREEN, A. R., Hall, J., & Rees, A. R. (1981) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1981.tb16806.x · Cited by 88

DOM-stimulus generalization to LSD and other hallucinogenic indolealkylamines

Glennon, R. A., Young, R., Jacyno, J. M., Slusher, M., & Rosecrans, J. A. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90196-6 · Cited by 67

The 5HT2 antagonist pirenperone reverses disruption of FR-40 by hallucinogenic drugs

Mokler, D. J., Stoudt, K. W., & Rech, R. H. (1985) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(85)90512-x · Cited by 27

1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI): From an Obscure to Pivotal Member of the DOX Family of Serotonergic Psychedelic Agents – A Review

Glennon, R. A., & Dukat, M. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00157 · Cited by 26

Serotonin and Serotonin Receptors in Hallucinogen Action

Halberstadt, A. L., & Nichols, D. E. (2010) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(10)70103-x · Cited by 26

Circadian rhythm of serotonin binding in rat brain

Wesemann, W., & Weiner, N. (1990) · Progress in Neurobiology · doi:10.1016/0301-0082(90)90029-g · Cited by 26

Stimulus effects of ibogaine in rats trained with yohimbine, DOM, or LSD

Palumbo, P. A., & Winter, J. C. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90506-b · Cited by 26

Effects of repeated treatment with 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) on the autoregulatory control of dorsal raphe 5-HT neuronal firing and cortical 5-HT release

Kidd, E. J., Garratt, J. C., & Marsden, C. A. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90675-g · Cited by 24

Psychedelic-like Properties of Quipazine and Its Structural Analogues in Mice

Revenga, M. D. L. F., Shah, U. H., Nassehi, N., Jaster, A. M., Hemanth, P., Sierra, S., Dukat, M., & González‐Maeso, J. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00291 · Cited by 23

Classical Hallucinogens

Glennon, R. A. (1996) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-60963-3_10 · Cited by 23

Mescaline: excitatory effects on acoustic startle are blocked by serotonin2 antagonists

Davis, M. (1987) · Psychopharmacology · doi:10.1007/bf00187244 · Cited by 23

Chronic Phenethylamine Hallucinogen Treatment Alters Behavioral Sensitivity to a Metabotropic Glutamate 2/3 Receptor Agonist

Benneyworth, M. A., Smith, R. L., & Sanders‐Bush, E. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301600 · Cited by 22

Stimulus effects of three sulfur-containing psychoactive agents

Khorana, N., Pullagurla, M. R., Dukat, M., Young, R., & Glennon, R. A. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.05.021 · Cited by 22

Behavioral effects of (�) 3,4-methylenedioxyamphetamine (MDA) and (�) 3,4-methylenedioxymethamphetamine (MDMA) in the pigeon: interactions with noradrenergic and serotonergic systems

Nader, M. A., Hoffmann, S. M., & Barrett, J. E. (1989) · Psychopharmacology · doi:10.1007/bf00444689 · Cited by 22

α-Adrenergic and 5-HT2-serotonergic effects of some β-phenylethylamines on isolated rat thoracic aorta

Sáez‐Briones, P., Borges, Y., Gonzalez, E., & Cassels, B. K. (1994) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(94)90035-3 · Cited by 21

The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The “Phenylalkylaminome” with a Focus on Selected Drugs of Abuse

Glennon, R. A. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00085 · Cited by 20

Designer drug 2,5-dimethoxy-4-methyl-amphetamine (DOM, STP): Involvement of the cytochrome P450 isoenzymes in formation of its main metabolite and detection of the latter in rat urine as proof of a drug intake using gas chromatography–mass spectrometry

Ewald, A. H., Puetz, M., & Maurer, H. H. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2007.11.042 · Cited by 20

Animal Models for Assessing Hallucinogenic Agents

Glennon, R. A. (2003) · Humana Press eBooks · doi:10.1385/0-89603-217-5:345 · Cited by 21

Evidence for 5-HT2 receptor mediation in quipazine anorexia

Shukla, R., MacKenzie-Taylor, D. R., & Rech, R. H. (1990) · Psychopharmacology · doi:10.1007/bf02245800 · Cited by 19

Pharmacology and Biochemistry of the 5-HT2 Receptor

Lyon, R. A., & Titeler, M. (1988) · Humana Press eBooks · doi:10.1007/978-1-4612-4560-5_3 · Cited by 18

The discriminative stimulus properties of the 5HT1 agonist RU24969

Gardner, C. R. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(89)90467-x · Cited by 18

Antimyoclonic properties of S2 serotonin receptor antagonists in the rat

Pranzatelli, M. R., & Snodgrass, S. R. (1986) · Neuropharmacology · doi:10.1016/0028-3908(86)90051-1 · Cited by 18

5-HT3 agonist 2-methylserotonin as a training drug in drug discrimination studies

Glennon, R. A., Young, R., & Dukat, M. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90111-r · Cited by 18

Discriminative Stimulus Effects of 1-(2,5-Dimethoxy-4-Methylphenyl)-2-Aminopropane in Rhesus Monkeys: Antagonism and Apparent p A2 Analyses

Li, J., Rice, K. C., & France, C. P. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.145458 · Cited by 16

Recent advances in central 5-hydroxytryptamine receptor agonists and antagonists

Arvidsson, L. E., Hacksell, U., & Glennon, R. A. (1986) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-9311-4_11 · Cited by 16

A suite of engineered mice for interrogating psychedelic drug actions

Chiu, Y.-T., Deutch, A. Y., Wang, W., Schmitz, G. P., Huang, K. L., Koçak, D. D., Llorach, P., Bowyer, K., Liu, B., Sciaky, N., et al. (2026) · Nature Neuroscience · doi:10.1038/s41593-026-02375-0 · Cited by 20

Discriminative Stimulus Effects of 1-(2,5-Dimethoxy-4-methylphenyl)-2-aminopropane (DOM), Ketanserin, and (R)-(+)-α-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipidinemethanol (MDL100907) in Rats

Li, J., Unzeitig, A., Javors, M. A., Rice, K. C., Koek, W., & France, C. P. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.157560 · Cited by 15

Distinct cognitive and discriminative stimulus effects of ketamine enantiomers in rats

Popik, P., Khoo, S. Y., Kuziak, A., Gołębiowska, J., Potasiewicz, A., Hogendorf, A. S., Popik, O., Matłoka, M., Moszczyński-Pętkowski, R., Nikiforuk, A., et al. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.173011 · Cited by 14

Synthesis of Novel (Phenylalkyl)amines for the Investigation of StructureActivity Relationships, Part 3

Trachsel, D. (2003) · Helvetica Chimica Acta · doi:10.1002/hlca.200390224 · Cited by 13

Agonists and antagonists of 5-HT2 receptors

Mylecharane, E. J. (1990) · Springer eBooks · doi:10.1007/978-94-009-0479-8_7 · Cited by 13

Characterization of a novel effect of serotonin 5-HT1A and 5-HT2A receptors: increasing cGMP levels in rat frontal cortex

Regina, M. J., Winter, J. C., & Rabin, R. A. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00287-9 · Cited by 12

Partial generalization of (−)DOM to fluvoxamine in the rat: implications for SSRI-induced mania and psychosis

Winter, J. C., Fiorella, D. J., Helsley, S., & Rabin, R. A. (1999) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145799001510 · Cited by 12

Effects of 2,5-Dimethoxy-4-Methylamphetamine (DOM) and 2-Piperazin-1-yl-Quinoline (Quipazine) on Fentanyl Versus Food Choice in Rhesus Monkeys

Maguire, D. R. (2022) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.122.001318 · Cited by 11

Pharmacology of 5-HT2 Receptors

Roth, B. L., & Hyde, E. G. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-60921-3_14 · Cited by 11

Role of Serotoninergic Neurons and 5-HT Receptors in the Action of Hallucinogens

Nichols, D. E. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-60921-3_21 · Cited by 11

Interactions of clozapine with the stimulus effects of DOM and LSD

Palumbo, P. A., & Winter, J. C. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90464-2 · Cited by 11

Receptor mechanisms for 5-hydroxytryptamine (5-HT) in isolated ovine umbilical vein

Zhang, L., & Dyer, D. C. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90620-l · Cited by 10

Quipazine Elicits Swallowing in the Arterially Perfused Rat Preparation: A Role for Medullary Raphe Nuclei?

Bergé-Laval, V., & Gestreau, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145120 · Cited by 10

Classification of opioid and 5-hydroxytryptamine receptors by means of discriminative drug effects

Stolerman, I. P. (1987) · Neuropharmacology · doi:10.1016/0028-3908(87)90064-5 · Cited by 10

d-Lysergic acid diethylamide differentially affects the dual actions of 5-hydroxytryptamine on cortical neurons

Pierce, P. A., & Peroutka, S. J. (1990) · Neuropharmacology · doi:10.1016/0028-3908(90)90122-8 · Cited by 10

Opiate-Serotonin Synergism Stimulating Luteinizing Hormone Release in Estrogen-Progesterone-Primed Ovariectomized Rats: Mediation by Serotonin2 Receptors*

Lenahan, S. E., Seibel, H. R., & JOHNSON, J. H. (1987) · Endocrinology · doi:10.1210/endo-120-4-1498 · Cited by 10

Clinical and preclinical evidence of psilocybin as antidepressant. A narrative review

Erkizia-Santamaría, I., Horrillo, I., Meana, J. J., & Ortega, J. E. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111249 · Cited by 12

Discovery and Structure–Activity Relationships of 2,5-Dimethoxyphenylpiperidines as Selective Serotonin 5-HT2A Receptor Agonists

Rørsted, E. M., Jensen, A. A., Šmits, G., Frydenvang, K., & Kristensen, J. L. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00082 · Cited by 8

Strategies for the Development of Selective Serotonergic Agents

Glennon, R. A. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-080-5_4 · Cited by 9

Development Assay for of a 5-Hydroxytryptamine2A Receptor Binding High Throughput Screening Using 96-Well Microfilter Plates

Harms, A., Gündisch, D., Müller, C. E., & Kovar, K.-A. (2000) · SLAS Discovery · doi:10.1177/108705710000500410 · Cited by 8

Struktur‐Wirkungs‐Beziehungen bei Nefopamhydrochlorid

Klüfers, P., Petersenn, A. V., & Röder, E. (1986) · Archiv der Pharmazie · doi:10.1002/ardp.19863190703 · Cited by 8

Pharmacology of serotonin neuronal systems

Ribeiro, C. (1991) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470060508 · Cited by 8

Biased Signaling in Psychedelic Action

Wacker, D., & McCorvy, J. D. (2025) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-062124-012545 · Cited by 9

Characterization of the discriminative stimulus properties of centrally administered (−)-DOM and LSD

Doat, M., Rabin, R. A., & Winter, J. C. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)01074-2 · Cited by 7

Effect of R(-)2,5-dimethoxy-4-methylamphetamine on uterine and umbilical blood flow in conscious pregnant sheep

Zhang, L., Dyer, D. C., Hembrough, F. B., & Isla, M. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90455-y · Cited by 7

Serotonin type 5A receptor antagonists inhibit D-lysergic acid diethylamide discriminatory cue in rats

Popik, P., Krawczyk, M., Kuziak, A., Bugno, R., Hogendorf, A. S., Staroń, J., & Nikiforuk, A. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119867603 · Cited by 7

Serotonergic/glutamatergic interactions: Potentiation of phencyclidine-induced stimulus control by citalopram

Winter, J. C., Eckler, J. R., Rice, K. C., & Rabin, R. A. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.03.022 · Cited by 7

Lack of a difference between ketanserin and ritanserin in central vs. peripheral serotonin receptor antagonism

Cohen, M. L., Bloomquist, W., Snoddy, H. D., & Fuller, R. W. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90507-9 · Cited by 7

Mianserin, a 5‐HT2receptor antagonist, in the treatment of delirium: an open study

Ikeguchi, K., & Kuroda, A. (1995) · European Journal of Neurology · doi:10.1111/j.1468-1331.1995.tb00082.x · Cited by 6

The Mauve Factor of Porphyria, 3‐Ethyl‐5‐hydroxy‐4,5‐dimethyl‐delta‐3‐pyrroline‐2‐one: Effects on Behaviour of Rats and Mice

Cutler, M. G., Graham, D. J. M., & Moore, M. R. (1990) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1990.tb00705.x · Cited by 6

The Role of Melatonin in the Antipsychotic and Motor-Side Effects of Neuroleptics: A Hypothesis

Sandyk, R., Kay, S. R., & Gillman, M. A. (1992) · International Journal of Neuroscience · doi:10.3109/00207459209000546 · Cited by 6

Neuropharmacological Studies of the Serotonergic System

Stephenson, J. D. (1990) · International Review of Psychiatry · doi:10.3109/09540269009028280 · Cited by 6

The origin of 2,5‐dimethoxy‐4‐methylamphetamine (DOM, STP)

Trout, K., & Daley, P. F. (2024) · Drug Testing and Analysis · doi:10.1002/dta.3667 · Cited by 5

Serotonergic mechanisms in schizophrenia: Evolution and current concepts

Meltzer, H. Y., Li, Z., Huang, M., & Prus, A. J. (2006) · Current Psychosis & Therapeutics Reports · doi:10.1007/bf02629409 · Cited by 4

Effects of Ketanserin, M100907 and Olanzapine on hallucinogenic like action induced by 2,5-dimethoxy-4-methylamphetamine

Li, K., Liu, X., Zhang, M., & Su, R. (2022) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000693 · Cited by 5

Synthesis and 5‐HT2A Radioligand Receptor Binding Assays of DOMCl and DOMOM, Two Novel 5‐HT2A Receptor Ligands

Harms, A., Ulmer, E., & Kovar, K. (2003) · Archiv der Pharmazie · doi:10.1002/ardp.200390014 · Cited by 5

Electrical stimulation of the dorsal raphe nucleus as a discriminative stimulus: Generalization to (±)-DOI

Mokler, D. J., Dixon, M., & Stambaugh, L. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90218-6 · Cited by 5

The effects of intracranial administration of hallucinogens on operant behavior in the rat I. lysergic acid diethylamide

Mokler, D. J., Stoudt, K. W., Sherman, L. C., & Rech, R. H. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90376-x · Cited by 5

The G protein biased serotonin 5-HT 2A receptor agonist lisuride exerts anti-depressant drug-like activities in micePreprint

Pogorelov, V. M., Rodriguiz, R. M., Roth, B. L., & Wetsel, W. C. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.01.543310 · Cited by 5

Quipazine: Classical hallucinogen? Novel psychedelic?

Glennon, R. A., & Dukat, M. (2023) · Australian Journal of Chemistry · doi:10.1071/ch22256 · Cited by 4

Making Sense of Psychedelics in the CNS

Fordyce, B. A., & Roth, B. L. (2024) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyae007 · Cited by 4

Discriminative Stimulus Characteristics of BMY 14802 in the Pigeon

Vanecek, S. A., Essman, W. D., Taylor, D. P., & Woods, J. H. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37194-0 · Cited by 4

Serotonin and serotonin receptors in hallucinogen action

Halberstadt, A. L., & Nichols, D. E. (2020) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-444-64125-0.00043-8 · Cited by 4

Pharmacological characterisation of psilocybin and 5-MeO-DMT discriminative cues in the rat and their translational value for identifying novel psychedelics

Higgins, G. A., MacMillan, C., de Lannoy, I., Tyler, C., & Slassi, M. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251361453 · Cited by 3

Effects of Ketanserin on the Discrimination of Electrical Stimulation of the Dorsal Raphé Nucleus in Rats * *Presented in part at the Society for Neuroscience Meeting, Miami Beach, 1994 (Mokler et al., 1994b).

Mokler, D. J., Abbruzzese, S., TRUMBLE, V., & Whitten, B. K. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00053-1 · Cited by 3

Disruption of FR-40 by 5-HT agonists. I. Effects of chronic imipramine or trazodone

Shukla, R., Dave, V., MacKenzie-Taylor, D. R., & Rech, R. H. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(89)90311-0 · Cited by 3

Drug Discrimination and Mechanisms of Drug Action

Glennon, R. A., & Young, R. (2011) · doi:10.1002/9781118023150.ch6 · Cited by 3

Classic psychedelics: past uses, present trends, future possibilitiesPreprint

Safron, A., & Johnson, M. W. (2022) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/eys2j · Cited by 3

Impure but not inactive: Behavioral pharmacology of dibenzylpiperazine, a common by-product of benzylpiperazine synthesis

Dolan, S. B., Shetty, R. A., Forster, M. J., & Gatch, M. B. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118780613 · Cited by 2

The effects of intracranial administration of hallucinogens on operant behavior in the rat. II. 2,5-Dimethoxy-4-methylamphetamine (DOM)

Mokler, D. J., Stoudt, K. W., Sherman, L. C., & Rech, R. H. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90448-5 · Cited by 2

Dual Modulation of 5-HT 2A Receptors and SERT by α-Ethyltryptamine and Its Optical Isomers

Silverman, J. M., Fiorillo, M., Younkin, J., Jones, C. B., Maltman, J. L., Herszenhorn, I., Artigas, A., Wolstenholme, J. T., Dukat, M., & González‐Maeso, J. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00468 · Cited by 1

Psilocybin induces stereotyped movements and reduces defensive responding in planarians through 5-hydroxytryptamine mechanisms

Akbar, R. J., Stringer, A. D., Wiah, S., Dachepalli, M., Daws, S. E., Inan, S., & Rawls, S. M. (2026) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000879 · Cited by 1

Substances of Abuse and Hallucinogenic Activity: The Serotoninergic Pathway - Focus on Classical Hallucinogens and Entactogens

Lazzaretti, M., Mandolini, G. M., Altamura, A. C., & Brambilla, P. (2018) · Springer eBooks · doi:10.1007/978-3-319-75124-5_2 · Cited by 1

Disruption of FR-40 by 5-HT agonists. II. Effects of chronic phenelzine or isocarboxazid

Shukla, R., Goudreau, J. L., MacKenzie-Taylor, D. R., & Rech, R. H. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(89)90312-2 · Cited by 1

Variability in the effects of 4-bromo-2,5-dimethoxyamphetamine (DOB) on operant behavior of squirrel monkeys

McKearney, J. W. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90157-8 · Cited by 1

Activity of prefrontal cortex serotonin 2A receptor expressing neurons is necessary for the head-twitch response of mice to psychedelic drug DOI in a sex-dependent mannerPreprint

Ozols, A. B., Wei, J., Campbell, J. M., Hu, C., Qiu, S., & Gallitano, A. L. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.21.595211 · Cited by 1

["PSD-95 Regulates Serotonin Receptor Function in vivo"]

Abbas, A. I. (2009) · OhioLink ETD Center (Ohio Library and Information Network)

Other Times I Can Barely See: The Effects of Hallucinogens on Vision and Attention

Baggott, M. J. (2010) · eScholarship (California Digital Library)

Communications

(1989) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1989.tb16851.x

Lysergic Acid Diethylamide and Mescaline

(2014) · John Wiley & Sons, Inc. eBooks · doi:10.1002/9781118850046.ch9

Effects of ayahuasca in preclinical studies with animals: a systematic review

Walsh-Monteiro, A., Morato, S., Uribe, F. A. R., Gouvêia, A., & Pedroso, J. D. S. (2025) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2025e14687

Effects of ketamine enantiomers on morphine and THC subjective effects in rats

Malikowska‐Racia, N., Golebiowska, J., Starowicz, K., Zajdel, P., Bisaga, A. M., & Popik, P. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251406839

Targeting serotonin 5-HT2A receptors in the treatment of aggression: From antipsychotics to psychedelics

Scheggi, S., Braccagni, G., Branca, C., & Bortolato, M. (2026) · Aggression and Violent Behavior · doi:10.1016/j.avb.2026.102139

Etude des réseaux moteurs du tronc cérébral impliqués dans l’activité rythmique des muscles des voies aériennes supérieures

Bergé-Laval, V. (2022) · doi:10.70675/113288c1zcad7z4c97z8e66zfa827c1455b2

Design of a new psychedelic quipazine analog with therapeutic efficacy and potentially fewer side effects

Younkin, J., Bansode, A. H., Saha, S., Paymode, A., Maltman, J. L., Jones, C. B., Silverman, J. M., Buzzi, B., Jaster, A. M., Fiorillo, M., et al. (2026) · Science Signaling · doi:10.1126/scisignal.adw6055

The Emergence of Isotryptamine Analogs as Novel Serotonergic Agents with Psychotherapeutic Potential

Glennon, R. A., & Dukat, M. (2026) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.6c00288

BindingDB Entry 50049209: The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The"Phenylalkylaminome" with a Focus on Selected Drugs of Abuse.

BindingDB (2019) · UC San Diego · doi:10.7270/q2dj5hwm

BindingDB Entry 50021054: Discovery and Structure-Activity Relationships of 2,5-Dimethoxyphenylpiperidines as Selective Serotonin 5-HT2A Receptor Agonists.

BindingDB (2025) · UC San Diego · doi:10.7270/q2mg7v4t

BindingDB Entry 50046173: Synthesis and pharmacological evaluation of N-benzyl substituted 4-bromo-2,5-dimethoxyphenethylamines as 5-HT2A/2C partial agonists.

BindingDB (2016) · UC San Diego · doi:10.7270/q2vx0j8w

Hallucinogens as a discriminative stimuli: Generalization of DOM to a 5-methoxy-N, N-dimethyltryptamine stimulus

Glennon, R. A., Rosecrans, J. A., Young, R., & Gaines, J. (1979) · Life Sciences · doi:10.1016/0024-3205(79)90317-5 · Cited by 42

Role of 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs II: reassessment of LSD false positives

Fiorella, D. J., Rabin, R. A., & Winter, J. C. (1995) · Psychopharmacology · doi:10.1007/bf02246075 · Cited by 73

Antagonism of the behavioral effects of 2,5-dimethoxy-4-methylamphetamine (DOM) and quipazine by metergoline

Commissaris, R. L., & Rech, R. H. (1981) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(81)90227-6 · Cited by 11

The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs I: Antagonist correlation analysis

Fiorella, D. J., Rabin, R. A., & Winter, J. C. (1995) · Psychopharmacology · doi:10.1007/bf02246074 · Cited by 137

Involvement of 5-HT receptor subtypes in the discriminative stimulus properties of mescaline

Appel, J. B., & Callahan, P. M. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90041-1 · Cited by 34